Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

microcin B17

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Microcin B17 (MccB17) is a 3.1-kDa Escherichia coli antibiotic that contains thiazole and oxazole heterocycles in a peptide… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1999
Highly Cited
1999
In the maturation of the Escherichia coli antibiotic Microcin B17 (MccB17), the McbA prepro-antibiotic is modified post… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Highly Cited
1999
Highly Cited
1999
BACKGROUND The Escherichia coli peptide antibiotic microcin B17 (MccB17) contains four oxazole and four thiazole rings, and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
1998
1998
BACKGROUND The peptide antibiotic microcin B17 (MccB17) contains oxazole and thiazole heterocycles formed by the post… Expand
1998
1998
BACKGROUND The Escherichia coli peptide antibiotic microcin B17 (MccB17) contains four oxazole and four thiazole rings introduced… Expand
Highly Cited
1997
Highly Cited
1997
Production of the antibacterial polypeptide microcin B17 (MccB17) by Escherichia coli ZK650 was inhibited by simulated… Expand
  • figure 1
  • table 2
  • table 1
Highly Cited
1995
Highly Cited
1995
Microcin B17 (McB17), the first known gyrase inhibitor of peptidic nature, is produced by ribosomal synthesis and post… Expand
Highly Cited
1994
Highly Cited
1994
Drugs that inhibit the activity of DNA gyrase fall almost exclusively into two structural classes, the quinolones and the… Expand
Highly Cited
1993
Highly Cited
1993
The maturation pathway of microcin B17 (MccB17), a ribosomally synthesized peptide antibiotic which inhibits DNA gyrase, has been… Expand
1985
1985
The production of the antibiotic substance microcin B17 (Mcc) is determined by a 3.5-kilobase DNA fragment from plasmid pMccB17… Expand